Northwest Biotherapeutics | NWBO - Loan Capital


Northwest Biotherapeutics reported $11.04M in Loan Capital for its fiscal quarter ending in September of 2023.





Loan Capital Change Date
Agenus USD 23.6M 448K Sep/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Eisai JPY 134.77B 12M Dec/2025
Infinity Pharmaceuticals USD 0 0 Jun/2022
Merck USD 39.97B 6B Sep/2025
Northwest Biotherapeutics USD 11.04M 4.7M Sep/2023
Pfizer USD 57.41B 93M Sep/2025
Plus Therapeutics USD 3.79M 322K Dec/2022
Roche Holding CHF 27.43B 966M Dec/2025